Fellowship · San Francisco, CA
Sponsored by Sutter Health
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 263 citations · Jennifer Guy
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
The New England journal of medicine · 2021 · 369 citations · Todd Frederick
Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022 · 102 citations · Kidist Yimam
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial.
The lancet. Gastroenterology & hepatology · 2026 · 12 citations · Kidist Yimam
Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
Gastroenterology · 2021 · 118 citations · Jennifer Guy
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study.
Hepatology communications · 2021 · 44 citations ·
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2024 · 10 citations · Todd Frederick
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023 · 20 citations · Jennifer Guy